Blood-based biomarkers of Alzheimer's disease: potential utility in clinical practice
{{output}}
Purpose of review: Blood-based biomarkers (BBMs) for Alzheimer's disease are beginning to enter clinical practice. As this integration advances, it is essential to critically examine their strengths, limitations, and readiness f... ...
